Press Releases

Date	Title	Company
14-Mar-2023	CeGaT Is One of the First Companies Worldwide to Receive the Most Powerful Sequencing Platform NovaSeq™ X Plus	CeGaT
14-Mar-2023	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury	Businesswire
14-Mar-2023	HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China	HUTCHMED
14-Mar-2023	ProQR Announces Successful Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing	ProQR
14-Mar-2023	Sengenics Corporation Announces Fredrik Sundberg as New Vice President of Market and Business Development	Businesswire
14-Mar-2023	Synaffix Announces Expansion of ADC Collaboration with MacroGenics	Synaffix
14-Mar-2023	Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023	Carterra
14-Mar-2023	Ferring announces abstract of the first prospective, multi-national, realworld study of Rekovelle® (follitropin delta) at the congress of the Pacific Society for Reproductive Medicine	Ferring Pharmaceuticals
14-Mar-2023	Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint achieved	Acesion Pharma
14-Mar-2023	Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases	Teitur Trophics
14-Mar-2023	Cell and Gene Therapy Catapult opens new Process Analytical Technologies laboratory	Cell and Gene Therapy Catapult
14-Mar-2023	Oragenics Announces Positive Results in Several Lantibiotics Compounds Against MRSA and VRE	Businesswire
14-Mar-2023	FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its Stock	Businesswire
14-Mar-2023	Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology	Businesswire
14-Mar-2023	Oral Route Medications Will Hold 55% of the Castration-Resistant Prostate Cancer (CRPC) Treatment Market \| FMI Study	MARKITWIRED
14-Mar-2023	OGT first to achieve IVDR-certification for FISH probes	OGT
14-Mar-2023	Pioneering biotech firm secures second FDA designation of year to develop world’s first treatment for rare, incurable and deadly disease	SynaptixBio
14-Mar-2023	ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19	ExeVir Bio
14-Mar-2023	Eureka Therapeutics Licenses Promising Antibody Targeting Mesothelin from the National Cancer Institute	Businesswire
14-Mar-2023	Aiosyn Launches AI-powered Automated Quality Control to Improve the Digital Pathology Workflow	Businesswire